Of note, no information on HMGB1 polymorphisms and prostate cancer risk was mentioned or discussed in the meta-analysis conducted by Li et al. [51], so the correlations of HMGB1 SNPs with prostate cancer risk and disease progression remain uncertain. The gene discussed is HMGB1; the disease is Familial prostate cancer.